Envision Pharma Group appoints Ryan Tubbs as Senior Vice President, Commercial Growth

New role brings commercial growth and client experience together to support a more connected approach for Envision’s life sciences clients
4 minute read

Envision Pharma Group has appointed Ryan Tubbs as Senior Vice President, Commercial Growth, a newly created role designed to strengthen alignment across the company’s commercial and client-facing functions.

Tubbs will lead Envision’s centralized commercial organization, bringing together sales enablement, lead generation, marketing, client implementation, and client experience. He will also help shape the company’s commercial strategy and operating model as Envision continues to expand its technology, market access, managed services, and medical communications offerings.

Reporting to Jay Ferro, President, Technology and Chief Product Officer, Tubbs will focus on connecting pre-sale and post-sale activities to create a more seamless experience for clients and enable stronger collaboration across Envision’s business units.

“Ryan has built and led high-performing commercial and customer organizations at scale,” says Tom Langan, CEO, Envision Pharma Group. “As we bring sales enablement, lead generation, marketing, and customer success together under one leader, Ryan is exactly the right person to build the connective tissue our clients and our business need, giving every business unit the infrastructure to grow and making it simpler for clients to access the full breadth of Envision.”

Tubbs brings more than 20 years of commercial and customer leadership experience across healthcare, life sciences, technology, and other enterprise sectors. Most recently, he served as SVP, Customer Success, Value & Managed Services at Ellucian, following 13 years in senior commercial and transformation roles at Microsoft. He also co-founded BillionMinds, a Techstars-backed workforce development company.

Tubbs adds, “Envision has extraordinary expertise, technology, and client relationships. The opportunity now is to connect those strengths into one commercial engine, making it easier for our teams to bring the best of Envision to every client and easier for clients to access the full value we can deliver.”

The move comes as Envision prepares to launch new offerings across its iEnvision®, market access, and managed services portfolios in the second half of 2026.

Author

Author name

Job role name

From the author

“Lorem ipsum dolor sit amet mas elitius geaiun garetein prouig mas qeuin”

Author

Author name

Job role name

News and views

How to accelerate strategic decision-making in biopharma...
Market access and pricing specialist to lead Envision's value optimization business...
Jun. 24, 2026
A look back at how the key development program has supported over 170 colleagues since its launch...